Wesley D. Kufel

Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections

Katie A Parsels, Keri A. Mastro, Jeffrey M. Steele et al. · Journal of Antimicrobial Chemotherapy · 2021 · 83 citations

Pharmacy, Infectious Diseases, Pharmacology +15

Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia

Bryan T. Mogle, Jeffrey M. Steele, Robert W. Seabury et al. · International Journal of Antimicrobial Agents · 2018 · 60 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +12

Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant <i>Enterobacterales</i> and <i>Pseudomonas aeruginosa</i>

Sara Alosaimy, Abdalhamid M Lagnf, Taylor Morrisette et al. · Open Forum Infectious Diseases · 2021 · 57 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Plasma and cerebrospinal fluid concentrations of cefiderocol during successful treatment of carbapenem-resistant <i>Acinetobacter baumannii</i> meningitis

Wesley D. Kufel, Yasmeen Abouelhassan, Jeffrey M. Steele et al. · Journal of Antimicrobial Chemotherapy · 2022 · 34 citations

Medicine, Infectious Diseases, Pharmacology +17

Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections

Nicholas Rebold, Taylor Morrisette, Abdalhamid M Lagnf et al. · Open Forum Infectious Diseases · 2021 · 32 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17